Clinical, genomic, and follow‑up data of patients with hematologic malignancies

This dataset contains baseline demographic information, cardiovascular risk factors, anthracycline exposure history, results of gene mutations related to hematologic malignancies, and follow‑up records of atrial fibrillation events from 1,160 patients with newly diagnosed hematologic malignancies treated at a tertiary hospital between November 2017 and September 2024. To protect patient privacy, the data are not publicly available.

De‑identified data may be obtained upon reasonable request, subject to institutional ethics approval and a data use agreement.